BVT Aktienanleihe PFE 30.12.2024/ DE000VM4AQB4 /
14/06/2024 20:02:56 | Var.-0.180 | Denaro21:59:23 | Lettera21:59:23 | Sottostante | Prezzo di esercizio | Expiration date | Tipo di opzione |
---|---|---|---|---|---|---|---|
100.030USD | -0.18% | - Quantità in denaro: - |
- Quantità in lettera: - |
Pfizer Inc | 30.00 USD | 30/12/2024 | Call |
GlobeNewswire
05:30
PHREESIA ALERT: Bragar Eagel & Squire, P.C. is Investigating Phreesia, Inc. on Behalf of Phreesia St...
GlobeNewswire
05:30
2U ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against 2...
GlobeNewswire
05:30
TERADATA ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Aga...
GlobeNewswire
05:30
RIVIAN DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has...
GlobeNewswire
05:30
CVS ALERT: Bragar Eagel & Squire, P.C. is Investigating CVS Health Corporation on Behalf of CVS Stoc...
GlobeNewswire
05:30
PERION DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has...
GlobeNewswire
05:30
LAMB WESTON ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed ...
Newsfile Corp
04:00
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Charge Enterprises, Inc. Investors to Secure Counsel ...
GlobeNewswire
03:31
Hampton Creek Press Author and NYT Bestseller J.D. Barker Unveiled as a Featured Speaker at the Auth...